Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
about
Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel Anti-CRR9/CLPTM1L Antibo ...... ction, and Survival Signaling.
@en
type
label
Novel Anti-CRR9/CLPTM1L Antibo ...... ction, and Survival Signaling.
@en
prefLabel
Novel Anti-CRR9/CLPTM1L Antibo ...... ction, and Survival Signaling.
@en
P2093
P2860
P1476
Novel Anti-CRR9/CLPTM1L Antibo ...... ction, and Survival Signaling.
@en
P2093
Gabor Szebeni
László G Puskás
László Tiszlavicz
Michael A James
Susan Tsai
P2860
P304
P356
10.1158/1535-7163.MCT-15-0717
P577
2016-03-03T00:00:00Z